The justices ruled that the authority of the judges of the Patent Trial and Appeal Board is unconstitutional, but by giving the USPTO director greater oversight, the highest court likely save...
https://medcitynews.com/2021/06/scotus-limits-patent-judges-power-but-preserves-ptab-review/
The value of intellectual property in a startup cannot be ignored. It is axiomatic that technology startups are the most attuned to the value of IP to their business — some form of technolo...
A vast number of healthcare regulatory burdens and intellectual property issues – many of which are frequently overlooked – can snag young digital health companies and either destroy thei...
https://medcitynews.com/2017/06/how-can-digital-health-companies-avoid-legal-missteps/
Telehealth company American Well has sued competitor Teladoc, claiming infringement of intellectual property rights. The post American Well sues Teladoc over telehealth intellectual property a...
https://medcitynews.com/2015/06/american-well-sues-teladoc-over-telehealth-intellectual-property/
When a startup gets ready for some M&A action (and if they’re in healthcare, getting to this point was probably hard-fought and hard-won), a patent troll could come knocking. While the Federal ...
https://medcitynews.com/2013/10/healthcare-startups-patent-trolls-got-check-wsjs-tips/
“Patents are one of the most painful parts of running a startup.” That was one of the responses Colleen Chien, an associate professor of Law at Santa Clare Law, got when she surveyed and inte...
Great Lakes NeuroTechnologies, a Cleveland-area company that promised more focus on DBS treatments as well as new products this year, has expanded its intellectual property in that area. The p...
Even before the Supreme Court ruled on Myriad Genetics yesterday, there was talk in the biotech industry that a decision against the company’s patents would spell bad news for innovation. Trade...
Passed in September 2011, the final phases of the America Invents Act went into effect in March. Cyrus Morton, a partner at the Minneapolis office of Robins, Kaplan, Miller & Ciresi said this law...
A piece in Forbes this week calls attention to a recent trend in technology commercialization at universities: the use of crowdfunding. The article focused on a collaboration between the Universi...
Last summer, when regenerative medicine company Stem Cell Theranostics went through the StartX accelerator program at Stanford University along with one other biotech company, the team members re...
Patent laws are changing. The America Invents Act has shifted U.S. patent laws to a “first-to-file” system from a “first-to-invent” system, according to attorney Steven Auvil, chair of th...
Purdue University spun off 11 new companies in 2010, making it the sixth most successful university technology commercialization program in the country for creating startups, according to the Ass...
A drug delivery technology patent awarded to BioDelivery Sciences International (NASDAQ:BDSI) has triggered a $15 million milestone payment from drug partner Endo Pharmaceuticals (NASDAQ:ENDP). R...
GlaxoSmithKline (NYSE:GSK) is investing nearly $800 million to build a new manufacturing plant in the United Kingdom, part of a capital investment effort that could create 1,000 new jobs. The new...
The experimental hepatitis C treatment that BioCryst Pharmaceuticals (NASDAQ:BCRX) wants to take into clinical trials this year has run into an unexpected hitch: a patent for the compound was a...
Drug delivery technology developed by BioDelivery Sciences International (NASDAQ:BDSI) has withstood another patent challenge from competitor MonoSol Rx. Specialty pharmaceutical company BDSI sai...
BioDelivery Sciences International (NASDAQ:BDSI) stands to gain a $15 million milestone payment after getting word that its drug delivery technology will be granted a patent for two drug treatmen...
North Carolina biotechnology company Precision BioSciences has secured a patent victory for its genome engineering technology. The U.S. Patent and Trademark Office has rejected claims from French...
https://medcitynews.com/2012/01/genome-engineering-firm-precision-biosciences-gets-patent-victory/
The government is working on shoring up patent processing for 2012, a move that can only help Uncle Sam’s relationship with healthcare entrepreneurs. The U.S. government has stepped up its publ...
This post is sponsored by Benesch. Newsflash — both houses of the U.S. Congress and the President agreed on something! Yes, our government agreed, by a wide margin, that it was necessary to m...
North Carolina biotechnology company DARA BioSciences (NASDAQ:DARA) has strengthened its intellectual position by securing five new patents for its drug pipeline. DARA said the five new patents w...
https://medcitynews.com/2011/11/dara-biosciences-gets-five-more-patents-for-pain-diabetes-portfolio/
A provision for fast track approval in the Leahy-Smith America Invents Patent Reform Act that went into effect this week could benefit some medical device companies. Meanwhile, it seems unlikely ...
https://medcitynews.com/2011/09/why-small-medical-device-companies-should-enjoy-patent-reform/
This post is sponsored by Benesch. Medical device and drug companies often contract with independent physicians to assist with product development. In the ideal situation, such physicians becom...
The patent cliff facing pharmaceutical companies has been staring down the industry for years, but even as companies now watch former blockbuster drugs tumble off its edge, many of those business...
Researchers at universities, similar to employees of medical device companies, are accustomed to assigning patent rights to their institution in an employment agreement signed during the hiring p...
This post is sponsored by Benesch. Valuation of a start-up is important for a variety of reasons. Obtaining capital, developing partnerships and preparing for an eventual exit strategy are just a...
https://medcitynews.com/2011/06/protecting-intellectual-property-can-boost-company-valuation/
Every week, MedCity news highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here’s the best of...
Intellectual property protection for DARA BioSciences‘s drug pipeline just got a little more secure. Raleigh, North Carolina-based DARA (NASDAQ:DARA) has been issued nine patents in the United ...
Pink eye drug AzaSite, a major component of Inspire Pharmaceutical‘s (NASDAQ:ISPH) portfolio and one of the key products sought by Merck (NYSE:MRK) in its $430 million acquisition of the North ...
https://medcitynews.com/2011/04/inspires-pink-eye-drug-azasite-draws-generic-challenge/